Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical (TEVA)
NYSE:TEVA
Holding TEVA?
Track your performance easily
Teva Pharmaceutical (TEVA) Ownership Overview
0.45% Insiders
6.22% Mutual Funds
29.97% Other Institutional Investors
3.23% ETFs
60.13% Public Companies and
Individual Investors
The ownership structure of Teva Pharmaceutical (TEVA) stock is a mix of institutional, retail, and individual investors. Approximately 39.42% of the company’s stock is owned by Institutional Investors, 0.45% is owned by Insiders, and 60.13% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 13, 2024 | Richard Daniell Exec. Vp, European Commercial | xxxxxxxxxxxxx | $1710724 |
| Aug 13, 2024 | Eric A Hughes Evp, Global R&d And Chief Medical Officer | xxxxxxxxxxxxx | $782692 |
| Jun 21, 2024 | Roberto Mignone Director | xxxxxxxxxxxxx | $8838570 |
| May 17, 2024 | Amir Weiss Cao | xxxxxxxxxxxxx | $470773 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $191732 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $418460 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $553033 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1239397 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 23,662,189 | Institution | 2.09% | 412,905,198 | |
| 18,899,451 | Institution | 1.67% | 329,795,420 | |
| 13,668,233 | Institution | 1.20% | 238,510,666 | |
| 8,456,324 | Institution | 0.75% | 147,562,854 | |
| 7,567,533 | Institution | 0.67% | 132,053,451 | |
| 5,996,836 | Institution | 0.53% | 104,644,788 | |
| 4,914,292 | Institution | 0.43% | 85,754,395 | |
| 4,611,294 | Institution | 0.41% | 80,467,080 | |
| 4,559,401 | Institution | 0.40% | 79,561,547 | |
| 4,244,900 | Institution | 0.37% | 74,073,505 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,899,451 | Institution | 1.67% | 329,795,420 | |
| 4,611,294 | Institution | 0.41% | 80,467,080 | |
| 4,244,900 | Institution | 0.37% | 74,073,505 | |
| 4,002,728 | Institution | 0.35% | 69,847,604 | |
| 3,609,490 | Institution | 0.32% | 62,985,601 | |
| 3,545,612 | Institution | 0.31% | 61,870,929 | |
| 3,251,712 | Institution | 0.29% | 56,742,374 | |
| 3,069,638 | Institution | 0.27% | 53,565,183 | |
| 2,979,500 | Institution | 0.26% | 51,992,275 | |
| 2,111,321 | Institution | 0.19% | 36,842,551 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,159,760 | Institution | 0.63% | 124,221,836 | |
| 3,697,089 | Institution | 0.33% | 64,144,494 | |
| 2,650,014 | Institution | 0.23% | 45,977,743 | |
| 1,431,577 | Institution | 0.13% | 24,837,861 | |
| 1,426,112 | Institution | 0.13% | 24,743,043 | |
| 1,301,224 | Institution | 0.11% | 22,576,236 | |
| 954,626 | Institution | 0.08% | 16,562,761 | |
| 879,720 | Institution | 0.08% | 15,263,142 | |
| 805,303 | Institution | 0.07% | 13,972,007 | |
| 546,513 | Institution | 0.05% | 9,482,001 |
FAQ
Who Owns Teva Pharmaceutical (TEVA)?
According to the latest TipRanks data, approximately 29.97% of the company's stock is held by institutional investors, 0.45% is held by insiders, and 60.13% is held by retail investors.
What percentage of Teva Pharmaceutical (TEVA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 29.97% of Teva Pharmaceutical (TEVA) stock is held by institutional investors.
What percentage of Teva Pharmaceutical (TEVA) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.13% of Teva Pharmaceutical (TEVA) stock is held by retail investors.
Who owns the most shares of Teva Pharmaceutical (TEVA)?
iShares owns the most shares of Teva Pharmaceutical (TEVA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.